Results 91 to 100 of about 19,551 (125)

GGT1 is a SNP eQTL gene involved in STAT3 activation and associated with the development of Post-ERCP pancreatitis. [PDF]

Sci Rep
Furukawa R, Kuwatani M, Jiang JJ, Tanaka Y, Hasebe R, Murakami K, Tanaka K, Hirata N, Ohki I, Takahashi I, Yamasaki T, Shinohara Y, Nozawa S, Hojyo S, Kubota SI, Hashimoto S, Hirano S, Sakamoto N, Murakami M.   +18 more
europepmc   +1 more source

Peptide-drug conjugates repolarize glioblastoma-associated macrophages to resensitize chemo-immunotherapy of glioblastoma. [PDF]

Sci Adv
Li Z, Jiang S, Wang J, Li W, Yang J, Liu W, Gao H, Huang Y, Ruan S.   +8 more
europepmc   +1 more source

Harnessing advanced computational approaches to design novel antimicrobial peptides against intracellular bacterial infections. [PDF]

Bioact Mater
Fang Y, Fan D, Feng B, Zhu Y, Xie R, Tan X, Liu Q, Dong J, Zeng W.   +8 more
europepmc   +1 more source

Dead or alive: how the immune system detects microbial viability

, 2019
Sander, L., Ugolini, M.
core   +1 more source

Hemodynamics in chronic pain: A pathway to multi-modal health risks. [PDF]

PLoS One
Davydov DM, Galvez-Sánchez CM, Reyes Del Paso GA.   +2 more
europepmc   +1 more source

Topical Ocular Drug Delivery: The Impact of Permeation Enhancers. [PDF]

Pharmaceutics
Santos G, Delgado E, Silva B, Braz BS, Gonçalves L.   +4 more
europepmc   +1 more source

Role of pyruvate kinase M2 in regulating sepsis (Review). [PDF]

Mol Med Rep
Hu Y, Tang J, Xu Q, Fang Z, Li R, Yang M, Zhao J, Chen X.   +7 more
europepmc   +1 more source

Bioconjugation of Podophyllotoxin and Nanosystems: Approaches for Boosting Its Biopharmaceutical and Antitumoral Profile. [PDF]

Pharmaceuticals (Basel)
Miranda-Vera C, Hernández ÁP, García-García P, Díez D, García PA, Castro MÁ.   +5 more
europepmc   +1 more source

Noncoding RNA-encoded peptides in cancer: biological functions, posttranslational modifications and therapeutic potential. [PDF]

J Hematol Oncol
Tan S, Yang W, Ren Z, Peng Q, Xu X, Jiang X, Wu Z, Oyang L, Luo X, Lin J, Xia L, Peng M, Wu N, Tang Y, Han Y, Liao Q, Zhou Y.   +16 more
europepmc   +1 more source

PCK1 as a target for cancer therapy: from metabolic reprogramming to immune microenvironment remodeling. [PDF]

Cell Death Discov
Liu N, Zhu XR, Wu CY, Liu YY, Chen MB, Gu JH.   +5 more
europepmc   +1 more source